ESMC
Price
$0.19
Change
+$0.02 (+11.76%)
Updated
Feb 19 closing price
Capitalization
2.08M
FONR
Price
$14.75
Change
+$0.04 (+0.27%)
Updated
Feb 21 closing price
Capitalization
131.33M
Ad is loading...

ESMC vs FONR

Header iconESMC vs FONR Comparison
Open Charts ESMC vs FONRBanner chart's image
Escalon Medical
Price$0.19
Change+$0.02 (+11.76%)
Volume$16.7K
Capitalization2.08M
Fonar
Price$14.75
Change+$0.04 (+0.27%)
Volume$6.9K
Capitalization131.33M
ESMC vs FONR Comparison Chart
Loading...
FONR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ESMC vs. FONR commentary
Feb 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ESMC is a Hold and FONR is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 24, 2025
Stock price -- (ESMC: $0.19 vs. FONR: $14.75)
Brand notoriety: ESMC and FONR are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ESMC: 179% vs. FONR: 50%
Market capitalization -- ESMC: $2.08M vs. FONR: $131.33M
ESMC [@Medical Specialties] is valued at $2.08M. FONR’s [@Medical Specialties] market capitalization is $131.33M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ESMC’s FA Score shows that 1 FA rating(s) are green whileFONR’s FA Score has 0 green FA rating(s).

  • ESMC’s FA Score: 1 green, 4 red.
  • FONR’s FA Score: 0 green, 5 red.
According to our system of comparison, ESMC is a better buy in the long-term than FONR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FONR’s TA Score shows that 5 TA indicator(s) are bullish.

  • FONR’s TA Score: 5 bullish, 5 bearish.

Price Growth

ESMC (@Medical Specialties) experienced а +21.61% price change this week, while FONR (@Medical Specialties) price change was -9.23% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.75%. For the same industry, the average monthly price growth was -1.45%, and the average quarterly price growth was +2.31%.

Reported Earning Dates

ESMC is expected to report earnings on Feb 19, 2025.

FONR is expected to report earnings on Feb 18, 2025.

Industries' Descriptions

@Medical Specialties (-1.75% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FONR($131M) has a higher market cap than ESMC($2.08M). FONR has higher P/E ratio than ESMC: FONR (11.06) vs ESMC (9.85). ESMC YTD gains are higher at: 50.199 vs. FONR (-2.573). FONR has higher annual earnings (EBITDA): 29.4M vs. ESMC (375K). FONR has more cash in the bank: 53.3M vs. ESMC (544K). ESMC has less debt than FONR: ESMC (973K) vs FONR (35.8M). FONR has higher revenues than ESMC: FONR (102M) vs ESMC (12M).
ESMCFONRESMC / FONR
Capitalization2.08M131M2%
EBITDA375K29.4M1%
Gain YTD50.199-2.573-1,951%
P/E Ratio9.8511.0689%
Revenue12M102M12%
Total Cash544K53.3M1%
Total Debt973K35.8M3%
FUNDAMENTALS RATINGS
ESMC vs FONR: Fundamental Ratings
ESMC
FONR
OUTLOOK RATING
1..100
5069
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
61
Fair valued
PROFIT vs RISK RATING
1..100
92100
SMR RATING
1..100
9381
PRICE GROWTH RATING
1..100
4078
P/E GROWTH RATING
1..100
244
SEASONALITY SCORE
1..100
48n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

FONR's Valuation (61) in the Medical Specialties industry is in the same range as ESMC (83). This means that FONR’s stock grew similarly to ESMC’s over the last 12 months.

ESMC's Profit vs Risk Rating (92) in the Medical Specialties industry is in the same range as FONR (100). This means that ESMC’s stock grew similarly to FONR’s over the last 12 months.

FONR's SMR Rating (81) in the Medical Specialties industry is in the same range as ESMC (93). This means that FONR’s stock grew similarly to ESMC’s over the last 12 months.

ESMC's Price Growth Rating (40) in the Medical Specialties industry is somewhat better than the same rating for FONR (78). This means that ESMC’s stock grew somewhat faster than FONR’s over the last 12 months.

ESMC's P/E Growth Rating (2) in the Medical Specialties industry is somewhat better than the same rating for FONR (44). This means that ESMC’s stock grew somewhat faster than FONR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
FONR
RSI
ODDS (%)
Bearish Trend 3 days ago
70%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
52%
Momentum
ODDS (%)
Bearish Trend 3 days ago
59%
MACD
ODDS (%)
Bearish Trend 3 days ago
61%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
66%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
60%
Advances
ODDS (%)
Bullish Trend 13 days ago
57%
Declines
ODDS (%)
Bearish Trend 4 days ago
68%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
70%
Aroon
ODDS (%)
Bullish Trend 3 days ago
56%
View a ticker or compare two or three
Ad is loading...
FONR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PIEQX16.90-0.13
-0.76%
T. Rowe Price International Eq Index
ARCHX17.86-0.15
-0.83%
Archer Balanced
FRRSX15.45-0.14
-0.90%
Franklin Real Estate Securities C
TWRCX47.51-1.17
-2.40%
American Century Growth C
CSGYX28.99-1.35
-4.45%
Columbia Small Cap Growth Inst3

ESMC and

Correlation & Price change

A.I.dvisor tells us that ESMC and MDRSF have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ESMC and MDRSF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ESMC
1D Price
Change %
ESMC100%
N/A
MDRSF - ESMC
21%
Poorly correlated
N/A
MASI - ESMC
9%
Poorly correlated
-4.09%
FONR - ESMC
8%
Poorly correlated
+0.28%
MDT - ESMC
8%
Poorly correlated
+2.27%
HBIO - ESMC
-1%
Poorly correlated
-16.10%
More

FONR and

Correlation & Price change

A.I.dvisor tells us that FONR and AZTA have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that FONR and AZTA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FONR
1D Price
Change %
FONR100%
+0.28%
AZTA - FONR
32%
Poorly correlated
-0.07%
OCX - FONR
30%
Poorly correlated
-2.57%
AVHHL - FONR
30%
Poorly correlated
+7.74%
KIDS - FONR
27%
Poorly correlated
-2.46%
ALGN - FONR
26%
Poorly correlated
-3.85%
More